200 related articles for article (PubMed ID: 19562778)
1. Wnt antagonist gene polymorphisms and renal cancer.
Hirata H; Hinoda Y; Nakajima K; Kikuno N; Yamamura S; Kawakami K; Suehiro Y; Tabatabai ZL; Ishii N; Dahiya R
Cancer; 2009 Oct; 115(19):4488-503. PubMed ID: 19562778
[TBL] [Abstract][Full Text] [Related]
2. Association of polymorphisms in Dickopff (DKK) gene towards modulating risk for lung cancer in north Indians.
Bahl C; Singh N; Behera D; Sharma S
Future Oncol; 2017 Feb; 13(3):213-232. PubMed ID: 27640551
[TBL] [Abstract][Full Text] [Related]
3. Genetic Variants in the Wingless Antagonist Genes (
Bahl C; Singh N; Behera D; Sharma S
Cancer Biother Radiopharm; 2018 Dec; 33(10):466-477. PubMed ID: 30346805
[No Abstract] [Full Text] [Related]
4. Significant Association Between Polymorphisms of Wnt Antagonist Genes and Lung Cancer.
Yilmaz M; Donmez G; Kacan T; Sari I; Akgül Babacan N; Sari M; Kilickap S
J Investig Med; 2015 Dec; 63(8):935-41. PubMed ID: 26457595
[TBL] [Abstract][Full Text] [Related]
5. Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways.
Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Kawakami K; Yamamura S; Ueno K; Majid S; Saini S; Ishii N; Dahiya R
Clin Cancer Res; 2009 Sep; 15(18):5678-87. PubMed ID: 19755393
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations of DICKKOPF family genes might not be associated with gastric cancer susceptibility.
Wu J; Zhang J; Zhan Z; Cao Q; Li Z
BMC Gastroenterol; 2016 Jul; 16(1):78. PubMed ID: 27457487
[TBL] [Abstract][Full Text] [Related]
7. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
8. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
[TBL] [Abstract][Full Text] [Related]
9. Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Eskander RN; Ali S; Dellinger T; Lankes HA; Randall LM; Ramirez NC; Monk BJ; Walker JL; Eisenhauer E; Hoang BH
Int J Gynecol Cancer; 2016 Jan; 26(1):125-32. PubMed ID: 26397159
[TBL] [Abstract][Full Text] [Related]
10. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
11. The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma.
Qin C; Cao Q; Ju X; Wang M; Meng X; Zhu J; Yan F; Li P; Ding Q; Chen J; Gu M; Zhang W; Yin C; Zhang Z
Ann Oncol; 2012 Apr; 23(4):981-9. PubMed ID: 21778301
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.
Dellinger TH; Planutis K; Jandial DD; Eskander RN; Martinez ME; Zi X; Monk BJ; Holcombe RF
Gynecol Oncol; 2012 Aug; 126(2):259-67. PubMed ID: 22555103
[TBL] [Abstract][Full Text] [Related]
13. The protease activated receptor 1 gene variation IVSn -14 A>T is associated with distant metastasis and cancer specific survival in renal cell carcinoma.
de Martino M; Haitel A; Schatzl G; Klatte T
J Urol; 2013 Oct; 190(4):1392-7. PubMed ID: 23517743
[TBL] [Abstract][Full Text] [Related]
14. Concurrent Hypermethylation of
Wang H; Duan XL; Qi XL; Meng L; Xu YS; Wu T; Dai PG
Mol Cells; 2017 Jan; 40(1):45-53. PubMed ID: 28152305
[TBL] [Abstract][Full Text] [Related]
15. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
[TBL] [Abstract][Full Text] [Related]
16. The association between polymorphisms in Wnt antagonist genes and bone response to hormone therapy in postmenopausal Korean women.
Kim H; Lee DO; Ku SY; Kim SH; Kim JH; Kim JG
Menopause; 2012 Sep; 19(9):1008-14. PubMed ID: 22668815
[TBL] [Abstract][Full Text] [Related]
17. Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
Liu GX; Zhang X; Li S; Koiiche RD; Sindsceii JH; Song H
Tumour Biol; 2013 Oct; 34(5):2741-6. PubMed ID: 23657965
[TBL] [Abstract][Full Text] [Related]
18. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma.
Ma R; Liu C; Lu M; Yuan X; Cheng G; Kong F; Lu J; Strååt K; Björkholm M; Ma L; Xu D
Urol Oncol; 2019 May; 37(5):301.e1-301.e10. PubMed ID: 30738744
[TBL] [Abstract][Full Text] [Related]
19. Association of CXCL12 and CXCR4 gene polymorphisms with the susceptibility and prognosis of renal cell carcinoma.
Cai C; Wang LH; Dong Q; Wu ZJ; Li MY; Sun YH
Tissue Antigens; 2013 Sep; 82(3):165-70. PubMed ID: 24032722
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
